Laminoplasty and In‐Site Regrafting for the Treatment of Thoracic Ossification of the Ligamentum Flavum: A Surgical Technique
Orthopaedic Surgery · 2025
DOI: 10.1111/os.14273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Orthopaedic Surgery, 2025. Verfasst von Hu Qian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Hauptthemen laut MEDLINE: Ligamentum Flavum, Ossification, Heterotopic, Laminoplasty, Thoracic Vertebrae. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Basic research program of Guizhou Province, Science and technology Bureau project of Zunyi city.
Abstract (Originalsprache)
Objective
Current surgical strategies for thoracic ossification of the ligamentum flavum (TOLF) are denounced by thoracic kyphosis, loss of spinal motion range, etc. A new surgical technique, laminoplasty and in‐site regrafting (LPIR), was modified to address the problems. This study aimed to report the safety and feasibility of LPIR for TOLF treatment.
Methods
This retrospective study reported the outcome of eight consecutive patients (3 males and 5 females, mean age 52.87 years) with TOLF who underwent LPIR surgery from January 2019 to March 2024. Pre‐ and post‐operative data including x‐ray, computerized tomography (CT), magnetic resonance imaging (MRI), the modified Japanese Orthopedic Association score (mJOA), the visual analog scale (VAS), and complications were collected to evaluate the outcome.
Results
All surgeries were performed successfully, significantly alleviating symptoms postoperatively. During an average follow‐up period of 28.63 months, the VAS score reduced from 4.50 ± 1.00 pre‐operatively to 1.63 ± 0.48 on the third post‐operative day and further reduced to 0.50 ± 0.70 during the last follow‐up. The mJOA score increased from 3.63 ± 0.70 pre‐operatively to 6.13 ± 0.78 on the third postoperative day and further increased to 8.88 ± 1.27 during the last follow‐up. No severe complications were observed.
Conclusions
LPIR exhibited significant safety and feasibility for treating TOLF, offering a novel strategy for managing this problem.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Department of Orthopaedic Surgery, Panzhou People's Hospital, Panzhou, China.
- Department of Orthopedic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
ORCID-Profile: Hu Qian
Förderung
- National Natural Science Foundation of China
- Basic research program of Guizhou Province
- Science and technology Bureau project of Zunyi city
- Doctoral start-up fund of Affiliated Hospital of Zunyi Medical University
Zitieren
APA
Qian, H., Wang, X., Lei, T., Ao, J., & Qin, J. (2025). Laminoplasty and In‐Site Regrafting for the Treatment of Thoracic Ossification of the Ligamentum Flavum: A Surgical Technique. Orthopaedic Surgery. https://doi.org/10.1111/os.14273
Vancouver
Qian H, Wang X, Lei T, Ao J, Qin J. Laminoplasty and In‐Site Regrafting for the Treatment of Thoracic Ossification of the Ligamentum Flavum: A Surgical Technique. Orthopaedic Surgery. 2025. doi:10.1111/os.14273
BibTeX
@article{Qian2025,
author = {Qian, Hu and Wang, Xiuqian and Lei, Ting and Ao, Jun and Qin, Jianpu},
title = {Laminoplasty and In‐Site Regrafting for the Treatment of Thoracic Ossification of the Ligamentum Flavum: A Surgical Technique},
journal = {Orthopaedic Surgery},
year = {2025},
doi = {10.1111/os.14273}
}
EUVIMED